Companies similar to STOKE THERAPEUTICS INC (STOK)
Health Care · NASDAQ
STOKE THERAPEUTICS INC (STOK)'s closest peers include Biogen (BIIB), ACADIA PHARMACEUTICALS INC (ACAD), Ionis Pharmaceuticals (IONS), PTC THERAPEUTICS INC (PTCT) and Ultragenyx (RARE). This peer set is drawn from STOK's enriched company profile and is informational only — not financial advice.
Similar companies
-
BiogenBIIBHealth Care
Biogen is a global biotechnology company developing and commercializing therapies across neurology, immunology, and rare genetic disease.
$203.16 (as of 2026-07-21) · market cap $29.7B
-
ACADIA PHARMACEUTICALS INCACADHealth Care
Acadia Pharmaceuticals is a biopharmaceutical company specializing in the development and commercialization of innovative therapies for CNS disorders and rare…
$25.43 (as of 2026-07-21) · market cap $4.3B
-
Ionis PharmaceuticalsIONSHealth Care
Pioneer in RNA-targeted antisense medicines with seven commercialized products and expanding late-stage pipeline across rare neurological and cardiometabolic…
$53.39 (as of 2026-07-21) · market cap $8.8B
-
PTC THERAPEUTICS INCPTCTHealth Care
PTC Therapeutics develops precision medicines and gene therapies targeting rare genetic disorders and serious diseases, generating revenue from approved…
$78.50 (as of 2026-07-21) · market cap $6.5B
-
UltragenyxRAREHealth Care
Ultragenyx is a biopharmaceutical company dedicated to developing and commercializing innovative therapies for serious, rare, and ultra-rare genetic diseases.
$28.62 (as of 2026-07-21) · market cap $2.8B
Not quite? Describe exactly what you want →
Peers are drawn from STOK's enriched profile (the same similarity signal the chat uses for "companies like STOK"). See the full profile: STOKE THERAPEUTICS INC (STOK).
Last updated 2026-07-21.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.